Randomized, placebo-controlled, double-blind study of a cytomegalovirus-specific monoclonal antibody (MSL-109) for prevention of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation
2001 ◽
Vol 7
(6)
◽
pp. 343-351
◽
2016 ◽
Vol 22
(3)
◽
pp. 528-535
◽
2008 ◽
Vol 197
(2)
◽
pp. 251-259
◽
2013 ◽
Vol 31
(8)
◽
pp. 743-753
◽
2017 ◽
Vol 10
(4)
◽
pp. 233-238
◽
2019 ◽
Vol 12
(11)
◽
pp. 937-945
◽